NewLeaf Symbiotics Completes Second Close of $30M Series C Financing

NewLeaf Symbiotics, a St. Louis, MO-based agriculture biologicals company, completed the second close of its $30m series C financing.

S2G Ventures (Seed 2 Growth) joined Monsanto Growth Ventures and Otter Capital. The Yard Ventures, (a Harvard alumni fund), Lewis & Clark Ventures, Rockport Capital, Pangaea Ventures, Open Prairie Ventures, and other investors also participated in the series C round.

Led by CEO Tom Laurita, NewLeaf is an agricultural biologicals company engaged in discovery, development, production, and commercialization of products containing beneficial plant bacteria.

The company intends to use the funds to commercialize seed treatment and in-furrow products for soybeans, corn, wheat, peanuts, and other crops as well as to expand the square footage of its R&D and pilot production facility in St. Louis and its proprietary Prescriptive Biologics Knowledgebase™ bioinformatics platform.



Join the discussion